Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A strong index level often signals robust momentum and potential persistence. Interpret carefully to adjust positions and risk exposure.
24,666 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
SoFi Technologies posted record fourth-quarter results and added a million members, yet the stock sits around $18. Th...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Three cruise stocks rise and fall on 2025 results and 2026 guidance. This report weighs Royal Caribbean, Carnival, an...
A May 2026 industry survey shows firms narrowing recruiting to a curated roster of schools and weighing GPA more heav...
A Roth IRA can dramatically boost after-tax income from dividend stocks that generate steady cash flow. This report b...
As rates shift in 2026, a tax-savvy strategy centers on a $750,000 municipal bond sleeve designed to generate steady,...
Original Medicare covers your doctor bills after the deductible, but the 20% coinsurance has no cap. As costs rise, r...
Oracle reports a powerful cloud quarter and record backlog, signaling a potential future milestone. Yet mounting capi...
Bloom Energy has climbed about 160% ytd, powered by a surge in AI-related data-center demand and new partnerships. Th...
Microsoft reported a sharp jump in capital spending as it doubles down on AI infrastructure. Four-quarter CapEx now t...
A refinancing wave is testing the arc of private credit’s influence on middle-market CRE, revealing a structural shif...